<?xml version="1.0" encoding="UTF-8"?>
<ref id="ijd15189-bib-0008">
 <label>8</label>
 <mixed-citation publication-type="journal" id="ijd15189-cit-0008">
  <string-name>
   <surname>Wang</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Rademaker</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Baker</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Foley</surname>
   <given-names>P</given-names>
  </string-name>. 
  <article-title>COVID‐19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australia/New Zealand consensus statement</article-title>. 
  <source xml:lang="en">Australas J Dermatol</source>
  <year>2020</year>; 
  <volume>61</volume>: 
  <fpage>210</fpage>–
  <lpage>216</lpage>. 
  <pub-id pub-id-type="doi">10.1111/ajd.13313</pub-id>
  <pub-id pub-id-type="pmid">32255510</pub-id>
 </mixed-citation>
</ref>
